CCND2 and diffuse large B-cell lymphoma: Wang's et al. study demonstrated that high cyclin D2 (CCND2) expression in ABC DLBCL was an independent prognostic indicator of PFS, potentially promoting further research on CCND2 inhibition and R-CHOP combination therapy [44].